{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:53:21Z","timestamp":1773924801813,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Brazilian National Council for Scientific and Technological Development","award":["305867\/2011-3"],"award-info":[{"award-number":["305867\/2011-3"]}]},{"name":"Brazilian National Council for Scientific and Technological Development","award":["478486\/2011-1"],"award-info":[{"award-number":["478486\/2011-1"]}]},{"name":"PROPESQ\/UEPB"},{"DOI":"10.13039\/501100003401","name":"FAPEAL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cbi.2017.12.009","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T00:38:19Z","timestamp":1512520699000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump"],"prefix":"10.1016","volume":"280","author":[{"given":"Natalina","family":"Dantas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago Mendon\u00e7a","family":"de Aquino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Xavier","family":"de Ara\u00fajo-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edeildo","family":"da Silva-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ednaldo Almeida","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoniel Augusto Severo","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Pinto","family":"Siqueira-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Jaime Bezerra","family":"Mendon\u00e7a Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2017.12.009_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/524891","article-title":"The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cbi.2017.12.009_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3201\/eid1506.081312","article-title":"Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007","volume":"15","author":"Finks","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cbi.2017.12.009_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2017.12.009_bib4","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/AAC.39.12.2650","article-title":"Inducible NorA-mediated multidrug resistance in Staphylococcus aureus","volume":"39","author":"Kaatz","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2017.12.009_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phytochem.2006.10.001","article-title":"Antibacterial and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana","volume":"68","author":"Smith","year":"2007","journal-title":"Phytochem"},{"key":"10.1016\/j.cbi.2017.12.009_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.37.1.128","article-title":"Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter","volume":"37","author":"Neyfakh","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2017.12.009_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1046\/j.1365-2958.2002.02965.x","article-title":"The mystery of multidrug transporters: the answer can be simple","volume":"44","author":"Neyfakh","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.cbi.2017.12.009_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2005.10.021","article-title":"Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view","volume":"71","author":"Lynch","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2017.12.009_bib9","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.ejmech.2010.05.006","article-title":"Substituted dihydronaphthalenes as efflux pump inhibitors of Staphylococcus aureus","volume":"45","author":"Totha","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2017.12.009_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/AAC.42.2.475","article-title":"QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanidines, and aminoguanidine hydrazones","volume":"42","author":"Mitchell","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2017.12.009_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jps.2600790615","article-title":"Synthesis and biological activity of aminoguanidine hydrazones of 2-pyridine and 4-pyridine and 4-quinoline carboxaldehydes","volume":"79","author":"Foye","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2017.12.009_bib12","series-title":"Goodman & Gilman: As bases farmacol\u00f3gicas da terap\u00eautica","article-title":"Catecolaminas, f\u00e1rmacos simp\u00e1tico mim\u00e9ticos e antagonistas dos receptores adren\u00e9rgicos, p 163\u2013203","author":"Hoffman","year":"2003"},{"key":"10.1016\/j.cbi.2017.12.009_bib13","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1021\/jm000095f","article-title":"Synthesis and biological activity of analogues of the antidiabetic\/antiobesity agent 3-guanidinopropionic acid: discovery of a novel aminoguanidino acetic acid antidiabetic agent","volume":"44","author":"Larsen","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2017.12.009_bib14","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0968-0896(00)00165-6","article-title":"Potential antitumor agents. Part 29: synthesis and potential coanthracyclinic activity of imidazo [2, 1-b] thiazole aminoguanidine hydrazones","volume":"8","author":"Andreani","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2017.12.009_bib15","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ejmech.2007.01.020","article-title":"Synthesis of novel 3-amino-2-(4-chloro-2-mercaptobenzenesulfonyl)-guanidine derivatives as potential antitumor agents","volume":"42","author":"BrzozowskI","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2017.12.009_bib16","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.bmcl.2010.01.031","article-title":"Novel molecular hybrids of cinnamic acids and aminoguanidine hydrazones as potential antitubercular agents","volume":"20","author":"Bairwa","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2017.12.009_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1097-0282(2001)62:1<9::AID-BIP20>3.0.CO;2-F","article-title":"NMR interaction studies of aromatic aminoguanidine hydrazones with micelles: model for mechanism of action of cationic antibiotics","volume":"62","author":"Borges","year":"2001","journal-title":"Biopolymers"},{"key":"10.1016\/j.cbi.2017.12.009_bib18","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.3390\/molecules17055095","article-title":"Synthesis, molecular properties prediction, and anti-staphylococcal activity of N-Acylhydrazones and new 1, 3, 4-oxadiazole derivatives","volume":"17","author":"Oliveira","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2017.12.009_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/cbdd.1427","article-title":"Synthesis and biological evaluation of tricyclic guanidine analogues of batzelladine K for antimalarial, antileishmanial, antibacterial, antifungal, and anti-HIV activities","volume":"81","author":"Ahmed","year":"2013","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.cbi.2017.12.009_bib20","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/molecules22091394","article-title":"Development and validation of HPLC-DAD and UHPLC-DAD methods for the simultaneous determination of guanilhydrazones derivatives employing a factorial design","volume":"22","author":"Brito","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2017.12.009_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/acph-2016-0015","article-title":"Preliminary in vitro evaluation of the anti-proliferative activity of guanylhydrazone derivatives","volume":"66","author":"Fran\u00e7a","year":"2016","journal-title":"Acta Pharm. Croat."},{"key":"10.1016\/j.cbi.2017.12.009_bib22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/ptr.2695","article-title":"Modulation of drug resistance in Staphylococcus aureus by a kaempferol glycoside from Herissantia tiubae (malvaceae)","volume":"23","author":"Falc\u00e3o-Silva","year":"2009","journal-title":"Phytother. Res."},{"key":"10.1016\/j.cbi.2017.12.009_bib23","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement","author":"NCCLS \u2013 National Committee for Clinical Laboratory Standards","year":"2005"},{"key":"10.1016\/j.cbi.2017.12.009_bib24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jac\/dkl460","article-title":"Bacterial efflux pump inhibitors from natural sources","volume":"59","author":"Stavri","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cbi.2017.12.009_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/1535370216688571","article-title":"Biological activities of Rosmarinus officinalis L. (rosemary) extract as analyzed in microorganisms and cells","volume":"242","author":"de Oliveira","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.cbi.2017.12.009_bib26","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2017.12.009_bib27","doi-asserted-by":"crossref","first-page":"14664","DOI":"10.1073\/pnas.1308127110","article-title":"Structure of the YajR transporter suggests a transport mechanism based on the conserved motif A","volume":"110","author":"Jiang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2017.12.009_bib28","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.cbi.2017.12.009_bib29","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2017.12.009_bib30","first-page":"1355","article-title":"PRODRG - a tool for high-throughput crystallography of protein-ligand complexes","volume":"D60","author":"Sch\u00fcttelkopf","year":"2004","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.cbi.2017.12.009_bib31","series-title":"The PyMOL Molecular Graphics System","author":"Delano","year":"2002"},{"key":"10.1016\/j.cbi.2017.12.009_bib32","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/np8002673","article-title":"Antibacterial cannabinoids from Cannabis sativa: a structure activity study","volume":"71","author":"Appendino","year":"2008","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.cbi.2017.12.009_bib33","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/np500281c","article-title":"In vitro antibacterial activity of prenylated guanidine alkaloids from pterogyne nitens and synthetic analogues","volume":"77","author":"Coqueiro","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.cbi.2017.12.009_bib34","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1016\/j.bmc.2008.09.042","article-title":"Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors","volume":"16","author":"Sangwan","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2017.12.009_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1128\/AAC.01306-05","article-title":"Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus","volume":"51","author":"Vidaillac","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2017.12.009_bib36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1021\/jm1011963","article-title":"Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus","volume":"54","author":"Brincat","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2017.12.009_bib37","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0960-894X(97)00312-0","article-title":"Molecular modeling of the interaction of tryponocide aminoguanidine hydrazones with B-DNA","volume":"17","author":"Santos-Filho","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2017.12.009_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/eji.200939819","article-title":"The antimicrobial activity of CCL28 is dependent on C-terminal positively charged amino acids","volume":"40","author":"Liu","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cbi.2017.12.009_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-642-78110-0_6","article-title":"The guanidinium group: its biological role and synthetic analogs","volume":"3","author":"Hannon","year":"1993","journal-title":"Bioorg. Chem. Front."},{"key":"10.1016\/j.cbi.2017.12.009_bib40","first-page":"138","article-title":"Inhibitors of bacterial efflux pumps as adjuvants in antibacterial therapy and diagnostic tools for detection of resistance by efflux","volume":"1","author":"van Bambeke","year":"2010","journal-title":"Front. Anti-Infect. Drug Disc."},{"key":"10.1016\/j.cbi.2017.12.009_bib41","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/jac\/dks232","article-title":"Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus","volume":"67","author":"Kalia","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cbi.2017.12.009_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","article-title":"Toward the estimation of the absolute quality of individual protein structure models","volume":"27","author":"Benkert","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cbi.2017.12.009_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature12014","article-title":"Structural basis for the drug extrusion mechanism by a MATE multidrug transporter","volume":"496","author":"Tanaka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2017.12.009_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1021\/jm0004190","article-title":"Flavono lignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships","volume":"44","author":"Guz","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2017.12.009_bib45","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2174\/138161211795703726","article-title":"Microbial efflux inhibition; tactics & strategies","volume":"17","author":"Tegos","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cbi.2017.12.009_bib46","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1055\/s-2002-36347","article-title":"Two flavonols from Artemisa annua, which potentiate the activity of berberine and against a norfloxacin resistant strain of Staphylococcus aureus","volume":"68","author":"Stermitz","year":"2002","journal-title":"Planta Med."},{"key":"10.1016\/j.cbi.2017.12.009_bib47","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.biochi.2005.04.012","article-title":"Bacterial efflux systems and efflux pumps inhibitors","volume":"87","author":"Marquez","year":"2005","journal-title":"Biochim"},{"key":"10.1016\/j.cbi.2017.12.009_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1874285801307010034","article-title":"Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation","volume":"7","author":"Kourtesi","year":"2013","journal-title":"Open Microbiol. J"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717310025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717310025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:46:37Z","timestamp":1757857597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717310025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":48,"alternative-id":["S0009279717310025"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2017.12.009","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}